Core Viewpoint - A securities class action lawsuit has been filed against 3D Systems Corporation for allegedly making false and misleading statements regarding its financial performance and business conditions during the class period from August 13, 2024, to May 12, 2025 [1][2]. Group 1: Allegations and Financial Performance - The lawsuit claims that 3D Systems understated the impact of weakened customer spending and overstated its resilience in challenging industry conditions [2]. - The updated milestone criteria in the United Partnership are alleged to negatively impact the Company's Regenerative Medicine Program revenue [2]. - 3D Systems reported Q4 2024 non-GAAP earnings-per-share of -$0.19, missing consensus estimates by $0.08, and sales revenue of $111 million, which is a -3.4% year-over-year decline [3]. - For the full year 2024, the Company reported sales of $440.1 million, a decrease of 10% compared to the prior year, attributed to lower hardware systems sales due to macroeconomic factors [3]. - A $9 million revenue reduction in Q4 was reported due to a change in accounting estimates for the Regenerative Medicine program [3]. - Following the financial results announcement, 3D Systems' stock price fell by $0.57 per share, or 20.96%, closing at $2.15 per share on March 27, 2025 [3]. Group 2: Legal Proceedings - Investors who purchased shares of 3D Systems are encouraged to contact the law firm Gainey McKenna & Egleston before the lead plaintiff motion deadline on August 12, 2025 [4]. - The lead plaintiff will act on behalf of other class members in directing the litigation [4].
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against 3D Systems Corporation (DDD)